Anthrax other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) No edit summary |
||
Line 14: | Line 14: | ||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Serial Monitoring}} | ! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Serial Monitoring}} | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[ | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[PCR]]''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" colspan=2| [[ | | style="background: #DCDCDC; padding: 5px; text-align: center;" colspan=2| Confirms [[virulence]] of [[Bacillus anthracis|organism]] by search for [[virulence factor]] [[genes]]<br>[[Primers]] to the [[toxin]] [[gene]]<br>[[Primer]] for the [[enzyme]] of [[capsule]] formation [[gene]] | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Lumbar puncture]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Lumbar puncture]]''' | ||
Line 24: | Line 24: | ||
| style="background: #DCDCDC; padding: 5px;"| As relevant to site of exposure<br>Evaluate edema<br>Evaluate inflammation<br>Evaluate necrosis | | style="background: #DCDCDC; padding: 5px;"| As relevant to site of exposure<br>Evaluate edema<br>Evaluate inflammation<br>Evaluate necrosis | ||
| style="background: #DCDCDC; padding: 5px;"| For [[headache]], [[confusion]] or other [[neurologic]] symptom<br>If [[meningitis]], [[meningeal signs]] will only be present at a later stage | | style="background: #DCDCDC; padding: 5px;"| For [[headache]], [[confusion]] or other [[neurologic]] symptom<br>If [[meningitis]], [[meningeal signs]] will only be present at a later stage | ||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[EKG]]''' | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" colspan=2| [[Atrial fibrillation]] with rapid [[ventricular]] response | |||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Echocardiogram]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Echocardiogram]]''' | ||
Line 30: | Line 32: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== |
Revision as of 00:50, 17 July 2014
Anthrax Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Anthrax other diagnostic studies On the Web |
American Roentgen Ray Society Images of Anthrax other diagnostic studies |
Risk calculators and risk factors for Anthrax other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Diagnostic Studies
Other studies to diagnose and monitor Anthrax infection and its potencial complications include:[1]
Test | Initial Findings | Serial Monitoring |
---|---|---|
PCR | Confirms virulence of organism by search for virulence factor genes Primers to the toxin gene Primer for the enzyme of capsule formation gene | |
Lumbar puncture | At admission unless contraindicated | Headache Confusion Other neurologic symptom If meningitis, meningeal signs will only be present at a later stage |
Other imaging | As relevant to site of exposure Evaluate edema Evaluate inflammation Evaluate necrosis |
For headache, confusion or other neurologic symptom If meningitis, meningeal signs will only be present at a later stage |
EKG | Atrial fibrillation with rapid ventricular response | |
Echocardiogram | Evaluate for pericardial effusion Evaluate for myocardial dysfunction |
References
- ↑ Hendricks, Katherine A.; Wright, Mary E.; Shadomy, Sean V.; Bradley, John S.; Morrow, Meredith G.; Pavia, Andy T.; Rubinstein, Ethan; Holty, Jon-Erik C.; Messonnier, Nancy E.; Smith, Theresa L.; Pesik, Nicki; Treadwell, Tracee A.; Bower, William A. (2014). "Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults". Emerging Infectious Diseases. 20 (2). doi:10.3201/eid2002.130687. ISSN 1080-6040.